WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹338 Cr | ₹298 Cr | ₹347 Cr | ₹284 Cr | ₹275 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹338 Cr |
Mar2023 | ₹298 Cr |
Mar2022 | ₹347 Cr |
Mar2021 | ₹284 Cr |
Mar2020 | ₹275 Cr |
How is Total Liabilities of WANBURY Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹338 Cr | 13.41 | |
Mar2023 | ₹298 Cr | -14.09 | |
Mar2022 | ₹347 Cr | 22.35 | |
Mar2021 | ₹284 Cr | 2.98 | |
Mar2020 | ₹275 Cr | - |
Compare Total Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹838.3 Cr | -6.4% | -3.9% | 30.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -6.4% |
-3.9% |
30.8% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses